Welcome to our dedicated page for Accenture plc SEC filings (Ticker: ACN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Accenture plc's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Accenture plc's regulatory disclosures and financial reporting.
Park Angie Y reported acquisition or exercise transactions in this Form 4 filing.
Accenture plc’s Chief Financial Officer Angie Y. Park received a grant of 24 Class A ordinary shares on a compensation basis. The Form 4 classifies this as a grant or award, with no purchase price paid per share.
The accompanying footnote explains that the grant reflects Restricted Share Units adjusted under anti-dilution provisions to account for Accenture’s payment of a cash dividend. Following this award, Park directly holds a total of 12,965 Class A ordinary shares, indicating a small, routine update to her equity position tied to existing RSU awards.
Nason Jennifer reported acquisition or exercise transactions in this Form 4 filing.
Accenture plc director Jennifer Nason reported updated share holdings. She received a grant of 9 Class A ordinary shares as Restricted Share Units at no cost, issued under anti-dilution provisions to reflect Accenture’s cash dividend, bringing her direct holdings to 923 shares.
The filing also records 403 Class A ordinary shares held indirectly through a limited liability company she owns, reflecting a transfer of 3 shares previously held directly to that LLC on February 13, 2026.
Travis Tracey Thomas reported acquisition or exercise transactions in this Form 4 filing.
Accenture plc director Travis Tracey Thomas received a grant of 15 Class A ordinary shares as a stock-based award. The award was issued at no cash cost per share and arose from anti-dilution adjustments to previously granted restricted share units following Accenture’s payment of a cash dividend. After this grant, Thomas directly holds 9,814 shares.
McKinstry Nancy reported acquisition or exercise transactions in this Form 4 filing.
Accenture plc director Nancy McKinstry received an equity award rather than trading shares on the market. On May 15, 2026, she was granted 12 Class A ordinary shares at $0.0000 per share as a compensation-related award.
The grant arises from Restricted Share Units (RSUs) issued under anti-dilution provisions to reflect Accenture plc's payment of a cash dividend. After this award, McKinstry directly holds 8,095 Class A ordinary shares, indicating a relatively small, routine adjustment to her existing equity position.
Jope Alan C. reported acquisition or exercise transactions in this Form 4 filing.
Accenture plc director Alan C. Jope received an award of 15 Class A ordinary shares as Restricted Share Units. The grant was made under anti-dilution provisions tied to Accenture’s cash dividend, slightly increasing his direct holdings to 3,209 shares. This is a routine, compensation-related adjustment rather than a market purchase or sale.
Accenture plc director Paula A. Price received an award of 15 Class A ordinary shares through restricted share units. The grant was recorded at a price of $0.00 per share and is described as a grant, award, or other acquisition rather than an open-market purchase.
The footnote explains that these restricted share units were granted under anti-dilution provisions tied to Accenture’s payment of a cash dividend, effectively adjusting prior RSU awards. After this grant, Price directly holds 8,547 Class A ordinary shares.
Accenture plc director and CEO Julie Sweet received an equity-based award tied to prior grants. She acquired 49 Class A ordinary shares on a grant or award basis at no cash price, increasing her direct holdings to 16,019 shares. The award reflects anti-dilution adjustments to earlier restricted share unit grants following Accenture’s payment of a cash dividend.
Accenture plc director Arun Sarin received an equity award tied to a prior dividend. He acquired 14 Class A ordinary shares at no cost, reflecting a grant of Restricted Share Units under anti-dilution provisions triggered by Accenture’s cash dividend. Following this adjustment, he holds 9,614 shares directly.
Accenture plc reported that its General Counsel and Corporate Secretary, Joel Unruch, acquired 90 Class A ordinary shares at a stated price of $0.0000 per share. The award reflects additional Restricted Share Units granted under anti-dilution provisions tied to Accenture’s cash dividend and brings his direct holdings to 27,878 shares.
Accenture plc Chief Strategy & Services Officer Manish Sharma acquired 104 Class A ordinary shares through a company equity program. The shares were obtained from Accenture under the Accenture Voluntary Equity Investment Program at a price of $176.995 per share. Following this compensation-related acquisition, Sharma directly holds 5,426 Class A ordinary shares.